These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 7578724)

  • 1. Return to the past: the case for antibody-based therapies in infectious diseases.
    Casadevall A; Scharff MD
    Clin Infect Dis; 1995 Jul; 21(1):150-61. PubMed ID: 7578724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Back to the future: antibody-based strategies for the treatment of infectious diseases.
    Oral HB; Ozakin C; Akdiş CA
    Mol Biotechnol; 2002 Jul; 21(3):225-39. PubMed ID: 12102547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-based therapies for emerging infectious diseases.
    Casadevall A
    Emerg Infect Dis; 1996; 2(3):200-8. PubMed ID: 8903230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogen-specific recombinant human polyclonal antibodies: biodefence applications.
    Bregenholt S; Haurum J
    Expert Opin Biol Ther; 2004 Mar; 4(3):387-96. PubMed ID: 15006732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of monoclonal antibody therapy in the treatment of infectious disease.
    Chmel H
    Am J Hosp Pharm; 1990 Nov; 47(11 Suppl 3):S11-5. PubMed ID: 2275476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human monoclonal antibodies for infectious diseases.
    Masuho Y
    Acta Paediatr Jpn; 1987 Aug; 29(4):571-3. PubMed ID: 3144894
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravenous immunoglobulin for infectious diseases: back to the pre-antibiotic and passive prophylaxis era?
    Bayry J; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
    Trends Pharmacol Sci; 2004 Jun; 25(6):306-10. PubMed ID: 15165745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-based therapies as anti-infective agents.
    Casadevall A
    Expert Opin Investig Drugs; 1998 Mar; 7(3):307-21. PubMed ID: 15991974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passive antibody therapies: progress and continuing challenges.
    Casadevall A
    Clin Immunol; 1999 Oct; 93(1):5-15. PubMed ID: 10497006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive immunity in prevention and treatment of infectious diseases.
    Keller MA; Stiehm ER
    Clin Microbiol Rev; 2000 Oct; 13(4):602-14. PubMed ID: 11023960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Passive antibody therapy for infectious diseases.
    Casadevall A; Dadachova E; Pirofski LA
    Nat Rev Microbiol; 2004 Sep; 2(9):695-703. PubMed ID: 15372080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [From the ancient serotherapy to naked antibodies: a century of successful targeted therapies].
    Watier H
    Med Sci (Paris); 2009 Dec; 25(12):999-1009. PubMed ID: 20035670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulators as an antimicrobial tool.
    Pirofski LA; Casadevall A
    Curr Opin Microbiol; 2006 Oct; 9(5):489-95. PubMed ID: 16931122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies for biodefense.
    Froude JW; Stiles B; Pelat T; Thullier P
    MAbs; 2011; 3(6):517-27. PubMed ID: 22123065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune therapy for infectious diseases at the dawn of the 21st century: the past, present and future role of antibody therapy, therapeutic vaccination and biological response modifiers.
    Buchwald UK; Pirofski L
    Curr Pharm Des; 2003; 9(12):945-68. PubMed ID: 12678861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody based target tailored antimicrobial chemotherapy - a new approach.
    Singla M
    Med Hypotheses; 2007; 68(5):957-9. PubMed ID: 17141970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic intervention of clinical sepsis with intravenous immunoglobulin, white blood cells and antibiotics.
    Fischer GW; Weisman LE
    Scand J Infect Dis Suppl; 1990; 73():17-21. PubMed ID: 2128662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-bacterial monoclonal antibodies: next generation therapy against superbugs.
    Wang H; Chen D; Lu H
    Appl Microbiol Biotechnol; 2022 Jun; 106(11):3957-3972. PubMed ID: 35648146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential of antibody-mediated immunity in the defence against biological weapons.
    Casadevall A; Pirofski LA
    Expert Opin Biol Ther; 2005 Oct; 5(10):1359-72. PubMed ID: 16197341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.